Here's Why Editas Medicine Inc. Bounced Up 20% in June

Jul 12 2017

Here's Why Editas Medicine Inc. Bounced Up 20% in JuneThe CRISPR stock took a beating at the end of May. Here's why it recovered somewhat last month.